ロード中...
Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions
Pancreatic cancer (PC) incidence rates are rapidly increasing in developed countries, with half the patients being metastatic at diagnosis. For decades, fluorouracil, then gemcitabine regimens were the preferred palliative first-line options for fit patients with metastatic PC. FOLFIRINOX (a combina...
保存先:
| 出版年: | Therap Adv Gastroenterol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557187/ https://ncbi.nlm.nih.gov/pubmed/28835777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17713879 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|